Note: This document contains side effect information about raloxifene. Some dosage forms listed on this page may not apply to the brand name Evista.
Summary
Common side effects of Evista include: infection, flu-like symptoms, hot flash, and sinusitis. Other side effects include: lower limb cramp. Continue reading for a comprehensive list of adverse effects.
Applies to raloxifene: oral tablet.
Warning
Oral route (Tablet)
Increased risk of deep vein thrombosis and pulmonary embolism have been reported. Women with active or past history of venous thromboembolism should not take raloxifene hydrochloride. Increased risk of death due to stroke occurred in a trial in postmenopausal women with documented coronary heart disease or at increased risk for major coronary events. Consider risk-benefit balance in women at risk for stroke.
Serious side effects of Evista
Along with its needed effects, raloxifene (the active ingredient contained in Evista) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Stop taking raloxifene and get emergency help immediately if any of the following effects occur:
Rare
- Coughing blood
- headache or migraine headache
- loss of or change in speech, coordination, or vision
- pain or numbness in chest, arm, or leg
- shortness of breath (unexplained)
Check with your doctor as soon as possible if any of the following side effects occur while taking raloxifene:
More common
- Bloody or cloudy urine
- chest pain
- difficult, burning, or painful urination
- fever
- frequent urge to urinate
- infection, including body aches or pain, congestion in throat, cough, dryness or soreness of throat, runny nose, and loss of voice
- leg cramping
- skin rash
- swelling of hands, ankles, or feet
- vaginal itching
Less common
- Abdominal pain (severe)
- aching body pains
- congestion in lungs
- decreased vision or other changes in vision
- diarrhea
- difficulty in breathing
- hoarseness
- loss of appetite
- nausea
- trouble in swallowing
- weakness
Other side effects of Evista
Some side effects of raloxifene may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common
- Hot flashes, including sudden sweating and feelings of warmth (especially common during the first 6 months of treatment)
- increased white vaginal discharge
- joint or muscle pain
- mental depression
- problems of stomach or intestines, including passing of gas, upset stomach, or vomiting
- swollen joints
- trouble in sleeping
- weight gain (unexplained)
For Healthcare Professionals
Applies to raloxifene: oral tablet.
Cardiovascular
Very common (10% or more): Hot flashes/hot flushes/vasodilation (28.7%), increased blood pressure
Common (1% to 10%): Varicose vein, venous thromboembolism (VTE)
Postmarketing reports: Death related to VTE[Ref]
Other
Very common (10% or more): Flu syndrome (16.2%), infection (15.1%), peripheral edema (14.1%)
Common (1% to 10%): Chest pain, fever[Ref]
Musculoskeletal
Very common (10% or more): Arthralgia (15.5%), muscle spasms/leg cramps (12.1%)
Common (1% to 10%): Myalgia, arthritis, tendon disorder[Ref]
Respiratory
Very common (10% or more): Sinusitis (10.3%), rhinitis (10.2%)
Common (1% to 10%): Bronchitis, pharyngitis, increased cough, pneumonia, laryngitis[Ref]
Dermatologic
Common (1% to 10%): Rash, sweating[Ref]
Endocrine
Common (1% to 10%): Breast pain/tenderness/enlargement[Ref]
Gastrointestinal
Common (1% to 10%): Nausea, diarrhea, dyspepsia, vomiting, flatulence, gastrointestinal disorder, gastroenteritis, abdominal pain[Ref]
Genitourinary
Common (1% to 10%): Vaginitis, urinary tract infection, cystitis, leukorrhea, uterine disorder, vaginal bleeding, endometrial disorder, vaginal hemorrhage, urinary tract disorder[Ref]
Hepatic
Common (1% to 10%): Cholelithiasis, cholecystectomy
Frequency not reported: Slightly decreased platelet counts, moderate increases in AST and/or ALT[Ref]
Metabolic
Common (1% to 10%): Weight gain[Ref]
Nervous system
Common (1% to 10%): Headache/migraine, syncope, vertigo, neuralgia, hypesthesia, stroke, death related to stroke[Ref]
Ocular
Common (1% to 10%): Conjunctivitis
Postmarketing reports: Retinal vein occlusion[Ref]
Psychiatric
Common (1% to 10%): Depression, insomnia[Ref]
Hematologic
Uncommon (0.1% to 1%): Thrombocytopenia[Ref]
Oncologic
Uncommon (0.1% to 1%): Benign endometrial polyps
Frequency not reported: Endometrial cancer, ovarian cancer, endometrial atrophy[Ref]
